| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.4 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |